News
| Date |
Title (click title to view article) |
| Sep 7, 2010 |
Bristol-Myers Squibb to Acquire ZymoGenetics |
| Aug 25, 2010 |
ZymoGenetics Announces Completion of Enrollment in Phase 2b Clinical
Trial with PEG-Interferon lambda in Hepatitis C |
| Aug 4, 2010 |
ZymoGenetics to Webcast Presentation at the Canaccord Annual Growth Conference |
| Aug 3, 2010 |
ZymoGenetics Reports Second Quarter 2010 Financial Results |
| Jul 12, 2010 |
ZymoGenetics to Host Conference Call and Webcast on August 3, 2010 to Discuss Second Quarter 2010 Financial Results |
| Jun 18, 2010 |
Lars Fruergaard Jørgensen Joins the ZymoGenetics Board of Directors |
| Jun 15, 2010 |
ZymoGenetics to Webcast Presentation at the Piper Jaffray Europe
Conference |
| Jun 5, 2010 |
ZymoGenetics Reports Positive IL-21 Phase 2 Results in Metastatic Melanoma |
| Jun 2, 2010 |
ZymoGenetics Initiates PEG-Interferon lambda Phase 2b Clinical Trial in Hepatitis C in Collaboration with Bristol-Myers Squibb |
